Foundation Fighting Blindness

News from the Foundation

FFB Partners with AGTC to Advance Gene Therapies into the Clinic

The Foundation Fighting Blindness (FFB) has announced that it is collaborating with Applied Genetic Technologies Corporation (AGTC), a leading gene therapy development company, to advance gene therapies for retinal degenerative diseases into clinical trials.
Read more...

Neurotech Treatment Shows Biological Effect in RP Clinical Studies

Neurotech’s innovative treatment employing Encapsulated Cell Technology (ECT) demonstrated a biological effect after 12 months for people with retinitis pigmentosa (RP), Usher syndrome, and choroideremia participating in two Phase II/III clinical trials. Both trials are being funded in-part by the Foundation Fighting Blindness.
Read more...

Promising Research Presented at 2009 ARVO Annual Meeting

Every year, thousands of eye researchers from around the world convene at the Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting to share the latest advances and breakthroughs in eye and vision research. ARVO’s Annual Meeting is regarded as the premier annual research conference for the ophthalmological community.
Read more...

Second Sight Recruiting More Participants for U.S. Retinal Prosthesis Study

Retinal implant offers partially restored vision for people with retinitis pigmentosa

Second Sight Medical Products, Inc., developer of the retinal prosthesis known as the Argus II, is seeking 10 additional participants for its feasibility clinical study in the United States. A total of 22 people have already participated in the three-year study, which is underway in the U.S., Europe, and Mexico.

Chapters

Select a state from the dropdown below to view local chapters.

Free Information

Other News
from Medical News Today